54 related articles for article (PubMed ID: 15798397)
1. Development of a non-radioactive, 384-well format assay to detect inhibitors of the mitogen-activated protein kinase kinase 4.
Togame H; Fuchikami K; Sagara A; Inbe H; Ziegelbauer K
Assay Drug Dev Technol; 2005 Feb; 3(1):65-76. PubMed ID: 15798397
[TBL] [Abstract][Full Text] [Related]
2. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin.
Kim JE; Kwon JY; Lee DE; Kang NJ; Heo YS; Lee KW; Lee HJ
Biochem Pharmacol; 2009 Feb; 77(3):412-21. PubMed ID: 19026990
[TBL] [Abstract][Full Text] [Related]
3. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
6. High yield purification of JNK1β1 and activation by in vitro reconstitution of the MEKK1→MKK4→JNK MAPK phosphorylation cascade.
Owen GR; Achilonu I; Dirr HW
Protein Expr Purif; 2013 Feb; 87(2):87-99. PubMed ID: 23147205
[TBL] [Abstract][Full Text] [Related]
7. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages.
Sanghera JS; Weinstein SL; Aluwalia M; Girn J; Pelech SL
J Immunol; 1996 Jun; 156(11):4457-65. PubMed ID: 8666821
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence polarization competition immunoassay for tyrosine kinases.
Seethala R
Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
10. A Protoberberine derivative HWY336 selectively inhibits MKK4 and MKK7 in mammalian cells: the importance of activation loop on selectivity.
Kim N; Park J; Gadhe CG; Cho SJ; Oh Y; Kim D; Song K
PLoS One; 2014; 9(4):e91037. PubMed ID: 24759688
[TBL] [Abstract][Full Text] [Related]
11. Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ; Davis RJ
Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition.
Lim NR; Thomas CJ; Silva LS; Yeap YY; Yap S; Bell JR; Delbridge LM; Bogoyevitch MA; Woodman OL; Williams SJ; May CN; Ng DC
Biochem J; 2013 Dec; 456(2):149-61. PubMed ID: 24032640
[TBL] [Abstract][Full Text] [Related]
15. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
17. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
18. Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis.
Rose DM; Winston BW; Chan ED; Riches DW; Gerwins P; Johnson GL; Henson PM
J Immunol; 1997 Apr; 158(7):3433-8. PubMed ID: 9120304
[TBL] [Abstract][Full Text] [Related]
19. Development of a fluorescence polarization bead-based coupled assay to target different activity/conformation states of a protein kinase.
Lu Z; Yin Z; James L; Syto R; Stafford JM; Koseoglu S; Mayhood T; Myers J; Windsor W; Kirschmeier P; Samatar AA; Malcolm B; Turek-Etienne TC; Kumar CC
J Biomol Screen; 2004 Jun; 9(4):309-21. PubMed ID: 15191648
[TBL] [Abstract][Full Text] [Related]
20. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice.
Ciallella JR; Saporito M; Lund S; Leist M; Hasseldam H; McGann N; Smith CS; Bozyczko-Coyne D; Flood DG
Eur J Pharmacol; 2005 May; 515(1-3):179-87. PubMed ID: 15904918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
